Phase i study of individualized stereotactic body radiotherapy of liver metastases

Journal of Clinical Oncology

Volumn 27, Issue 10, 2009, Pages 1585-1591

  Lee, Mark T ^a   Kim, John J ^a   Dinniwell, Robert ^a   Brierley, James ^a   Lockwood, Gina ^a   Wong, Rebecca ^a   Cummings, Bernard ^a   Ringash, Jolie ^a   Tse, Regina V ^a   Knox, Jennifer J ^a   Dawson, Laura A ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ABDOMINAL WALL HERNIA; ACUTE TOXICITY; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BREAST CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CHRONIC TOXICITY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COHORT ANALYSIS; COLITIS; COLORECTAL CANCER; DUODENUM BLEEDING; DYSPEPSIA; ESOPHAGITIS; FEMALE; GASTRITIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INOPERABLE CANCER; LETHARGY; LIVER DISEASE; LIVER DYSFUNCTION; LIVER METASTASIS; LIVER PAIN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT SAFETY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION SAFETY; RIB FRACTURE; RISK REDUCTION; SKIN TOXICITY; SMALL INTESTINE OBSTRUCTION; SPLENECTOMY; STEREOTACTIC BODY RADIATION THERAPY; THORAX PAIN; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIOSURGERY;

EID: 63749117198     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.20.0600     Document Type: Article

References (37)

1. Steele G Jr, Ravikumar T: Resection of hepatic metastases from colorectal cancer: Biologic perspective. Ann Surg 210:127-138, 1989
2. Yoon SS, Tanabe KK: Surgical treatment and other regional treatments for colorectal cancer liver metastases. Oncologist 4:197-208, 1999
3. Scheele J, Stangl R, Altendorf-Hofmann A: Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history. Br J Surg 77:1241-1246, 1990
4. Cummings L, Payes J, Cooper G: Survival after hepatic resection in metastatic co orecta cancer: A population-based study. Cancer 109:718-726, 2007
5. Weiss L, Grundmann E, Torhorst J, et al: Haematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies. J Pathol 150:195-203, 1986
6. Kemeny MM, Adak S, BG, et al: Combined- modality treatment for resectable metastatic colo- rectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-An intergroup study. J Clin Oncol 20:1499-1505, 2002
7. Harrison LE, Brennan MF, Newman E, et al: Hepatic resection for noncolorectal, nonneuroendo- crine metastases: A fifteen-year experience with ninety-six patients. Surgery 121:625-632, 1997
8. Leonard G, Brenner B, Kemeny N: Neoadju- vant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 23:2038-2048, 2005
9. Wei AC, Greig PD, Grant D, et al: Survival after hepatic resection for colorectal metastases: A 10-year experience. Ann Surg Oncol 13:668-676, 2006
10. Adson M: Resection of liver metastases: When is it worthwhile? World J Surg 11:511-520, 1987
11. Fong Y: Surgical therapy of hepatic colorectal metastasis. CA Cancer J Clin 49:231-255, 1999
12. Rubin P, Brasacchio R, Katz A: Solitary metas- tases: Illusion versus reality. Semin Radiat Oncol 16:120-130, 2006
13. Ercolani G, Grazi G, Ravaioli M, et al: The role of liver resections for noncolorectal, nonneuroendo- crine metastases: Experience with 142 observed cases. Ann Surg Oncol 12:459-466, 2005
14. Lawrence TS, Robertson JM, Anscher MS, et al: Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31:1237-1248, 1995
15. Mohiuddin M, Chen E, Ahmad N: Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer. J Clin Oncol 14:722-728, 1996
16. Ben-Josef E, Normolle D, Ensminger WD, et al: Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 23:8739-8747, 2005
17. Kavanagh BD, Schefter TE, Cardenes HR, et al: Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 45:848-855, 2006
18. Katz A, Carey-Sampson M, Muhs A, et al: Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 67:793-798, 2007
19. Blomgren H, Lax I, Goranson H, et al: Radio- surgery for tumors in the body: Clinical experience using a new method. J Radiosurg 1:63-74, 1998
20. Herfarth KK, Debus J, Wannenmacher M: Stereotactic radiation therapy of liver metastases: Update of the initial phase-I/II trial. Front Radiat Ther Oncol 38:100-105, 2004
21. Wulf J, Hadinger U, Oppitz U, et al: Stereo-tactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177:645-655, 2001
22. Schefter TE, Kavanagh BD, Timmerman RD, et al: A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62:1371-1378, 2005
23. Dawson LA, Eccles C, Craig T: Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 45:856-864, 2006
24. Tse RV, Hawkins M, Lockwood G, et al: Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26:657-664, 2008
25. Wong JW, Sharpe MB, Jaffray DA, et al: The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys 44:911-919, 1999
26. Dawson LA, Brock KK, Kazanjian S, et al: The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys 51:1410-1421, 2001
27. Kutcher GJ, Burman C: Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 16:1623-1630, 1989
28. Lyman J: Complication probability as assessed from dose-volume histograms. Radiat Res 8:S13-S19, 1985 (suppl)
29. Dawson LA, Normolle D, Balter JM, et al: Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53:810-821, 2002
30. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216, 2000
31. Hoyer M, Roed H, Traberg Hansen A, et al: Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 45:823-830, 2006
32. Wulf J, Guckenberger M, Haedinger U, et al: Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 45:838-847, 2006
33. Mendez Romero A, Wunderink W, Hussain SM, et al: Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study. Acta Oncol 45:831-837, 2006
34. Sato M, Uematsu M, Yamamoto F, et al: Feasibility of frameless stereotactic high-dose radiation therapy for primary or metastatic liver cancer. J Radiosurg 1:233-238, 1998
35. Wurm RE, Gum F, Erbel S, et al: Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience. Acta Oncol 45:881-889, 2006
36. Dawson LA, Jaffray DA: Advances in image- guided radiation therapy. J Clin Oncol 25:938-946, 2007
37. Verellen D, De Ridder M, Storme G: A (short) history of image-guided radiotherapy. Radiother Oncol 86:4-13, 2008